Max Healthcare Institute Ltd
MAXHEALTH
주식 순위
#2329
Max Healthcare Institute Limited provides medical and healthcare services in... Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
주가
$8.62
시가총액
$8.39B
변동 (1일)
-4.46%
변동 (1년)
-36.99%
국가
IN
거래 Max Healthcare Institute Ltd (MAXHEALTH)
카테고리
Healthcare
Max Healthcare Institute Ltd (MAXHEALTH)의 매출
Jun 2026 기준 매출 TTM: $961.45M
Max Healthcare Institute Ltd의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $961.45M입니다. 2025년에 회사는 $821.79M의 수익을 올렸으며 이는 2024년의 $648.33M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Max Healthcare Institute Ltd의 수익 기록 (2014 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $961.45M | 16.99% |
| 2025 | $821.79M | 26.75% |
| 2024 | $648.33M | 16.78% |
| 2023 | $555.19M | 7.06% |
| 2022 | $518.58M | 51.37% |
| 2021 | $342.60M | 143.71% |
| 2020 | $140.58M | -42.37% |
| 2019 | $243.93M | -8.21% |
| 2018 | $265.75M | 7.14% |
| 2017 | $248.03M | 14.57% |
| 2016 | $216.50M | 71.10% |
| 2015 | $126.54M | -19.69% |
| 2014 | $157.57M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $78.01B | 8,014.09% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 2,168.65% |
US
|
|
| $3.89B | 305.11% |
SA
|
|
| $11.08B | 1,052.94% |
BR
|
